Education
About Us
Working with TipRanks
Follow Us
MACLEOD CHRISTOPHER ROSS Insider Profile
4 Followers
MACLEOD CHRISTOPHER ROSS, Director at Zomedica, holds 143.00K shares in Zomedica (Ticker: ZOMDF). Most recently, MACLEOD CHRISTOPHER ROSS Bought 143,000 shares of Zomedica on Mar 18, 2025 for an estimated value of $7.15K.
MACLEOD CHRISTOPHER ROSS has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of MACLEOD CHRISTOPHER ROSS's holdings
Insider Roles
Director
Roles that MACLEOD CHRISTOPHER ROSS holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by MACLEOD CHRISTOPHER ROSS
MACLEOD CHRISTOPHER ROSS's Trading History
List of latest transactions for each holding click on a transaction to see MACLEOD CHRISTOPHER ROSS's performance on stock
You May Also Like
MACLEOD CHRISTOPHER ROSS insider profile FAQ
What is the percentage of profitable transactions made by MACLEOD CHRISTOPHER ROSS?
The percentage of profitable transactions made by MACLEOD CHRISTOPHER ROSS is ―.
What is the average return per transaction made by MACLEOD CHRISTOPHER ROSS?
The average return per transaction made by MACLEOD CHRISTOPHER ROSS is ―.
What stocks does MACLEOD CHRISTOPHER ROSS hold?
MACLEOD CHRISTOPHER ROSS holds: ZOMDF stocks.
What was MACLEOD CHRISTOPHER ROSS’s latest transaction?
MACLEOD CHRISTOPHER ROSS latest transaction was an Informative Buy of $7.15K.
What was MACLEOD CHRISTOPHER ROSS's most profitable transaction?
MACLEOD CHRISTOPHER ROSS’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is MACLEOD CHRISTOPHER ROSS's role in Zomedica?
MACLEOD CHRISTOPHER ROSS's role in Zomedica is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.